HLA B5701
Clinical Significance
The presence of HLA B5701 indicates a very high risk of severe cutaneous adverse drug reactions to Abacavir. Testing is recommended prior to treatment.
Method
SSO (Sequence Specific Oligonucleotide) detection
Specimen EDTA whole blood (dedicated tube)